vs
布鲁克（BRKR）与因美纳（ILMN）财务数据对比。点击上方公司名可切换其他公司
因美纳的季度营收约是布鲁克的1.1倍（$1.1B vs $977.2M）。因美纳净利率更高（16.8% vs 2.7%，领先14.2%）。布鲁克同比增速更快（-0.2% vs -1.6%）。因美纳自由现金流更多（$335.0M vs $207.2M）。过去两年布鲁克的营收复合增速更高（16.4% vs 0.8%）
布鲁克公司是美国科学仪器制造商，总部位于马萨诸塞州比勒里卡，为公开上市企业。公司产品服务于分子与材料研究、工业及应用分析领域，旗下设有布鲁克科学仪器、布鲁克能源与超导技术（BEST）两大业务板块。
因美纳是总部位于美国加利福尼亚州圣迭戈的生物技术企业，成立于1998年4月，专注研发、生产及销售用于分析基因变异与生物功能的集成系统，产品及服务覆盖测序、基因分型、基因表达、蛋白质组学等领域，业务遍及全球超155个国家和地区。
BRKR vs ILMN — 直观对比
营收规模更大
ILMN
是对方的1.1倍
$977.2M
营收增速更快
BRKR
高出1.4%
-1.6%
净利率更高
ILMN
高出14.2%
2.7%
自由现金流更多
ILMN
多$127.8M
$207.2M
两年增速更快
BRKR
近两年复合增速
0.8%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $977.2M | $1.1B |
| 净利润 | $26.0M | $186.0M |
| 毛利率 | 46.0% | 65.9% |
| 营业利润率 | 7.8% | 15.8% |
| 净利率 | 2.7% | 16.8% |
| 营收同比 | -0.2% | -1.6% |
| 净利润同比 | 89.8% | 205.7% |
| 每股收益（稀释后） | $0.10 | $1.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BRKRILMN
| Q4 25 | $977.2M | — | ||
| Q3 25 | $860.5M | — | ||
| Q2 25 | $797.4M | — | ||
| Q1 25 | $801.4M | — | ||
| Q4 24 | $979.6M | $1.1B | ||
| Q3 24 | $864.4M | $1.1B | ||
| Q2 24 | $800.7M | $1.1B | ||
| Q1 24 | $721.7M | $1.1B |
净利润BRKRILMN
| Q4 25 | $26.0M | — | ||
| Q3 25 | $-59.6M | — | ||
| Q2 25 | $7.6M | — | ||
| Q1 25 | $17.4M | — | ||
| Q4 24 | $13.7M | $186.0M | ||
| Q3 24 | $40.9M | $705.0M | ||
| Q2 24 | $7.6M | $-2.0B | ||
| Q1 24 | $50.9M | $-126.0M |
毛利率BRKRILMN
| Q4 25 | 46.0% | — | ||
| Q3 25 | 44.1% | — | ||
| Q2 25 | 44.9% | — | ||
| Q1 25 | 48.8% | — | ||
| Q4 24 | 50.4% | 65.9% | ||
| Q3 24 | 48.4% | 69.0% | ||
| Q2 24 | 48.0% | 64.8% | ||
| Q1 24 | 48.9% | 62.0% |
营业利润率BRKRILMN
| Q4 25 | 7.8% | — | ||
| Q3 25 | -6.0% | — | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | 4.0% | — | ||
| Q4 24 | 7.4% | 15.8% | ||
| Q3 24 | 7.9% | 68.6% | ||
| Q2 24 | 6.0% | -147.2% | ||
| Q1 24 | 9.0% | -10.3% |
净利率BRKRILMN
| Q4 25 | 2.7% | — | ||
| Q3 25 | -6.9% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | 1.4% | 16.8% | ||
| Q3 24 | 4.7% | 65.3% | ||
| Q2 24 | 0.9% | -178.8% | ||
| Q1 24 | 7.1% | -11.7% |
每股收益（稀释后）BRKRILMN
| Q4 25 | $0.10 | — | ||
| Q3 25 | $-0.41 | — | ||
| Q2 25 | $0.05 | — | ||
| Q1 25 | $0.11 | — | ||
| Q4 24 | $0.09 | $1.16 | ||
| Q3 24 | $0.27 | $4.42 | ||
| Q2 24 | $0.05 | $-12.48 | ||
| Q1 24 | $0.35 | $-0.79 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $298.8M | $93.0M |
| 总债务越低越好 | $1.9B | — |
| 股东权益账面价值 | $2.5B | $2.4B |
| 总资产 | $6.2B | $6.3B |
| 负债/权益比越低杠杆越低 | 0.76× | — |
8季度趋势，按日历期对齐
现金及短期投资BRKRILMN
| Q4 25 | $298.8M | — | ||
| Q3 25 | $293.1M | — | ||
| Q2 25 | $92.0M | — | ||
| Q1 25 | $184.2M | — | ||
| Q4 24 | $183.4M | $93.0M | ||
| Q3 24 | $148.1M | $70.0M | ||
| Q2 24 | $169.7M | $74.0M | ||
| Q1 24 | $340.1M | — |
总债务BRKRILMN
| Q4 25 | $1.9B | — | ||
| Q3 25 | $2.0B | — | ||
| Q2 25 | $2.4B | — | ||
| Q1 25 | $2.1B | — | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.2B | — | ||
| Q1 24 | $1.4B | — |
股东权益BRKRILMN
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.8B | — | ||
| Q4 24 | $1.8B | $2.4B | ||
| Q3 24 | $1.8B | $2.1B | ||
| Q2 24 | $1.8B | $1.4B | ||
| Q1 24 | $1.4B | $5.7B |
总资产BRKRILMN
| Q4 25 | $6.2B | — | ||
| Q3 25 | $6.4B | — | ||
| Q2 25 | $6.3B | — | ||
| Q1 25 | $5.9B | — | ||
| Q4 24 | $5.8B | $6.3B | ||
| Q3 24 | $6.1B | $6.0B | ||
| Q2 24 | $5.9B | $6.1B | ||
| Q1 24 | $4.5B | $10.0B |
负债/权益比BRKRILMN
| Q4 25 | 0.76× | — | ||
| Q3 25 | 0.83× | — | ||
| Q2 25 | 1.34× | — | ||
| Q1 25 | 1.15× | — | ||
| Q4 24 | 1.18× | — | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 0.97× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $229.8M | $364.0M |
| 自由现金流经营现金流 - 资本支出 | $207.2M | $335.0M |
| 自由现金流率自由现金流/营收 | 21.2% | 30.3% |
| 资本支出强度资本支出/营收 | 2.3% | 2.6% |
| 现金转化率经营现金流/净利润 | 8.84× | 1.96× |
| 过去12个月自由现金流最近4个季度 | $43.3M | $709.0M |
8季度趋势，按日历期对齐
经营现金流BRKRILMN
| Q4 25 | $229.8M | — | ||
| Q3 25 | $-33.2M | — | ||
| Q2 25 | $-127.5M | — | ||
| Q1 25 | $65.0M | — | ||
| Q4 24 | $190.0M | $364.0M | ||
| Q3 24 | $38.4M | $316.0M | ||
| Q2 24 | $1.1M | $80.0M | ||
| Q1 24 | $21.8M | $77.0M |
自由现金流BRKRILMN
| Q4 25 | $207.2M | — | ||
| Q3 25 | $-54.1M | — | ||
| Q2 25 | $-148.8M | — | ||
| Q1 25 | $39.0M | — | ||
| Q4 24 | $153.3M | $335.0M | ||
| Q3 24 | $5.8M | $284.0M | ||
| Q2 24 | $-23.5M | $49.0M | ||
| Q1 24 | $400.0K | $41.0M |
自由现金流率BRKRILMN
| Q4 25 | 21.2% | — | ||
| Q3 25 | -6.3% | — | ||
| Q2 25 | -18.7% | — | ||
| Q1 25 | 4.9% | — | ||
| Q4 24 | 15.6% | 30.3% | ||
| Q3 24 | 0.7% | 26.3% | ||
| Q2 24 | -2.9% | 4.4% | ||
| Q1 24 | 0.1% | 3.8% |
资本支出强度BRKRILMN
| Q4 25 | 2.3% | — | ||
| Q3 25 | 2.4% | — | ||
| Q2 25 | 2.7% | — | ||
| Q1 25 | 3.2% | — | ||
| Q4 24 | 3.7% | 2.6% | ||
| Q3 24 | 3.8% | 3.0% | ||
| Q2 24 | 3.1% | 2.8% | ||
| Q1 24 | 3.0% | 3.3% |
现金转化率BRKRILMN
| Q4 25 | 8.84× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -16.78× | — | ||
| Q1 25 | 3.74× | — | ||
| Q4 24 | 13.87× | 1.96× | ||
| Q3 24 | 0.94× | 0.45× | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 0.43× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BRKR
| Bsi Nano | $309.1M | 32% |
| Bsi Biospin | $267.0M | 27% |
| Other | $179.9M | 18% |
| Transferred Over Time | $142.5M | 15% |
| Energy And Supercon Technologies | $69.5M | 7% |
ILMN
| Sequencing | $1.0B | 91% |
| Microarray | $101.0M | 9% |
| Investee | $7.0M | 1% |
